Company intelligence / Profile preview

iRiS Kinetics

Winter Garden, Florida, United Statesiriskinetics.com ↗

Ownership: Private
Development stage: Commercial

Overview

iRiS Kinetics has commercialized a label-free, multiplexed microarray platform using interferometric reflectance imaging to measure real-time binding kinetics of proteins, nucleic acids, peptides, and small molecules. The system is highly sensitive (<250 Da), quantitative, repeatable, and supports hundreds of probes per run. It is intended for research use in bioprocessing and antibody development but is not cleared for clinical diagnostics.

Modalities: ProteinNucleic acidPeptidesSmall molecule
Industry: Drug Discovery Services

Partnerships

Atlas University collaboration on laboratory establishmentBoston University academic collaboration/founder relationship

Beyond the preview

Go deeper on iRiS Kinetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iRiS Kinetics.

Explore the full profile